Work

Assessing real-world recurrence in high-risk (HR) non-muscle-invasive bladder cancer (NMIBC) treated with bacillus Calmette-Guérin (BCG) in the United States through a recurrence algorithm: A SEER-Medicare study.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.4601

Authors: Yair Lotan, Rituparna Bhattacharya, Honghao Fang, Sandy S. Chang, Yizhen Lai, Shujing Zhang, Jiayang Li, Pangsibo Shen, Wei Gao, Yan Song, Hema Dave, Haojie Li

Institutions: The University of Texas Southwestern Medical Center, Merck & Co., Inc., Rahway, NJ, USA (United States), Analysis Group (United States)

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410818784

Cites:

Cited by: 2

Related to: 10